By a GenomeWeb staff reporter

NEW YORK (GenomeWeb News) – Mitochondrial mutations could hold new opportunities for researchers seeking to develop cancer diagnostics, according to the National Cancer Institute, which has issued a new grant program to fund scientists who will study this possibility.

NCI plans to fund research that will validate new mitochondrial-related cancer biomarkers for early detection, diagnosis, prognosis, risk assessment, and response to treatments.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

In Science this week: mtDNA analysis give glimpse into decline of Neanderthals in Europe, and more.

The University of Arizona's Raina Maier writes that an understanding of the Earth's microbiome is needed.

The proposed Canadian budget emphasizes partnerships with industry, Nature News reports.

An Australian study of personalized medicine has run into problems as it recruits patients.

Apr
29
Sponsored by
Covance

This online seminar will review case studies demonstrating the clinical utility of CTCs and cfDNA to define and characterize a variety of dynamic genomic changes throughout the course of cancer detection and treatment.